We recently found that ANP suppresses E‐selectin expression in vascular endothelial cells, resulting in suppression of cancer cell metastasis 39; consequently, we have initiated a multicenter randomized clinical trial to examine the use of perioperative administration of ANP to prevent cancer recurrence after lung cancer surgery. This evidence concerns the gene SELE and lung cancer.